May 19, 2005 article Open access The macro domain is an ADP‐ribose binding module The EMBO Journal DOI: 10.1038/sj.emboj.7600664 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 12 stored of 521 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Dimerization of human PARP15 is required for NAD + binding and automodification 2026 FEBS Journal article Medicine PARP inhibition in cancer therapy Open access 0 citations Parp7 generates an ADP-ribosyl degron that controls negative feedback of androgen signaling 2025 The EMBO Journal article Medicine Prostate Cancer Treatment and Research Open access 10 citations Evolutionary and molecular basis of ADP-ribosylation reversal by zinc-dependent macrodomains 2024 Journal of Biological Chemistry article Biochemistry, Genetics and Molecular Biology Biochemical and Molecular Research Open access 8 citations Pathological and physiological roles of ADP-ribosylation: established functions and new insights 2024 Biological Chemistry article Medicine PARP inhibition in cancer therapy 3 citations Mono‐ADP‐Ribosylation of Peptides: An Overview of Synthetic and Chemoenzymatic Methodologies 2024 ChemBioChem article Biochemistry, Genetics and Molecular Biology Chemical Synthesis and Analysis Open access 6 citations PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities 2023 Science Advances article Medicine PARP inhibition in cancer therapy Open access 75 citations PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities 2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine PARP inhibition in cancer therapy Open access 4 citations Intracellular mono-ADP-ribosyltransferases at the host–virus interphase 2022 Cellular and Molecular Life Sciences article Immunology and Microbiology interferon and immune responses Open access 31 citations The search for inhibitors of macrodomains for targeting the readers and erasers of mono-ADP-ribosylation 2021 Drug Discovery Today article Medicine PARP inhibition in cancer therapy 21 citations Engineering Af1521 improves ADP-ribose binding and identification of ADP-ribosylated proteins 2020 Nature Communications article Biochemistry, Genetics and Molecular Biology Biochemical and Structural Characterization Open access cited by 2 patents 90 citations Comparative analysis of MACROD1, MACROD2 and TARG1 expression, localisation and interactome 2020 Scientific Reports article Biochemistry, Genetics and Molecular Biology Cancer-related gene regulation Open access 43 citations The Controversial Roles of ADP-Ribosyl Hydrolases MACROD1, MACROD2 and TARG1 in Carcinogenesis 2020 Cancers article Medicine PARP inhibition in cancer therapy Open access 31 citations 12 results References 0